- Filed
- Dec 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Nov 2, 2025 | 425.5M sh |
| Shares Diluted | Q3 2025 · Nov 2, 2025 | 426.4M sh |
| Shares Diluted restated | Q3 2025 · Oct 27, 2024 | 426.6M sh |
| Shares Diluted restated | Q3 2025 · Oct 27, 2024 | 433.6M sh |
| Stock Repurchased | Q3 2025 · Nov 2, 2025 | $207.5M |
| Stock Repurchased restated | Q3 2025 · Oct 27, 2024 | $875.2M |
| Capex | Q3 2025 · Nov 2, 2025 | $97.8M |
| Capex restated | Q3 2025 · Oct 27, 2024 | $92.9M |
| Operating Cash Flow | Q3 2025 · Nov 2, 2025 | $428.2M |
| Operating Cash Flow restated | Q3 2025 · Oct 27, 2024 | $388.8M |
| Cash And Equivalents | Q3 2025 · Nov 2, 2025 | $675.4M |
| Cash And Equivalents | Q3 2025 · Feb 2, 2025 | $595.8M |
| Stockholders Equity | Q3 2025 · Nov 2, 2025 | $469.4M |
| Stockholders Equity | Q3 2025 · Aug 3, 2025 | $389.9M |
| Stockholders Equity | Q3 2025 · Feb 2, 2025 | $261.5M |
| Stockholders Equity restated | Q3 2025 · Oct 27, 2024 | $223.4M |
| Stockholders Equity restated | Q3 2025 · Jul 28, 2024 | $486.8M |
| Stockholders Equity restated | Q3 2025 · Jan 28, 2024 | $510.3M |
| Current Liabilities | Q3 2025 · Nov 2, 2025 | $2.26B |
| Current Liabilities | Q3 2025 · Feb 2, 2025 | $2.21B |
| Total Liabilities | Q3 2025 · Nov 2, 2025 | $2.83B |
| Total Liabilities | Q3 2025 · Feb 2, 2025 | $2.75B |
| Current Assets | Q3 2025 · Nov 2, 2025 | $1.93B |
| Current Assets | Q3 2025 · Feb 2, 2025 | $1.66B |
| Total Assets | Q3 2025 · Nov 2, 2025 | $3.29B |
| Total Assets | Q3 2025 · Feb 2, 2025 | $3.01B |
| Eps Diluted | Q3 2025 · Nov 2, 2025 | $0.14 |
| Eps Diluted | Q3 2025 · Nov 2, 2025 | $0.43 |
| Eps Diluted | Q3 2025 · Oct 27, 2024 | $0.01 |
| Eps Diluted | Q3 2025 · Oct 27, 2024 | $0.85 |
| Eps Basic | Q3 2025 · Nov 2, 2025 | $0.14 |
| Eps Basic | Q3 2025 · Nov 2, 2025 | $0.44 |
| Eps Basic | Q3 2025 · Oct 27, 2024 | $0.01 |
| Eps Basic | Q3 2025 · Oct 27, 2024 | $0.87 |
| Sga Expense | Q3 2025 · Nov 2, 2025 | $665.1M |
| Sga Expense | Q3 2025 · Nov 2, 2025 | $1.99B |
| Sga Expense restated | Q3 2025 · Oct 27, 2024 | $626.5M |
| Sga Expense restated | Q3 2025 · Oct 27, 2024 | $1.85B |
| Net Income | Q3 2025 · Nov 2, 2025 | $59.2M |
| Net Income | Q3 2025 · Nov 2, 2025 | $183.6M |
| Net Income restated | Q3 2025 · Oct 27, 2024 | $3.9M |
| Net Income restated | Q3 2025 · Oct 27, 2024 | $369.9M |
| Operating Income | Q3 2025 · Nov 2, 2025 | $65.2M |
| Operating Income | Q3 2025 · Nov 2, 2025 | $211.8M |
| Operating Income restated | Q3 2025 · Oct 27, 2024 | $25.6M |
| Operating Income restated | Q3 2025 · Oct 27, 2024 | $122.3M |
| Gross Profit | Q3 2025 · Nov 2, 2025 | $928.2M |
| Gross Profit | Q3 2025 · Nov 2, 2025 | $2.79B |
| Gross Profit restated | Q3 2025 · Oct 27, 2024 | $843.9M |
| Gross Profit restated | Q3 2025 · Oct 27, 2024 | $2.54B |
| Cost Of Revenue | Q3 2025 · Nov 2, 2025 | $2.19B |
| Cost Of Revenue | Q3 2025 · Nov 2, 2025 | $6.54B |
| Cost Of Revenue restated | Q3 2025 · Oct 27, 2024 | $2.03B |
| Cost Of Revenue restated | Q3 2025 · Oct 27, 2024 | $6.07B |
| Revenue | Q3 2025 · Nov 2, 2025 | $3.12B |
| Revenue | Q3 2025 · Nov 2, 2025 | $9.34B |
| Revenue restated | Q3 2025 · Oct 27, 2024 | $2.88B |
| Revenue restated | Q3 2025 · Oct 27, 2024 | $8.61B |